Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08OMM
|
|||
| Former ID |
DIB007803
|
|||
| Drug Name |
BL-1040
|
|||
| Indication | Myocardial infarction [ICD-11: BA41-BA43; ICD-9: 410] | Phase 1/2 | [1] | |
| Company |
BioLineRx
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00557531) Safety and Feasibility of the Injectable BL-1040 Implant. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.